Is Aytu Biopharma Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Aytu Biopharma Inc (AYTU) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Aytu Biopharma Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Aytu Biopharma Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Aytu Biopharma Inc?

Muslim investors may consider investing in Aytu Biopharma Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Aytu Biopharma Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Aytu Biopharma Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Aytu Biopharma Inc updated?

The Shariah compliance status of Aytu Biopharma Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Aytu Biopharma Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Aytu Biopharma Inc?

You can check the latest Shariah compliance status of Aytu Biopharma Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

AYTU Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: February 10, 2026

Report Source: 2026 2nd Quarter Report

Aytu Biopharma Inc. Stock Analysis AYTU

United States Health Care Nano Cap Report: Q2, 2026

Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. The company is headquartered in Denver, Colorado and currently employs 82 full-time employees. The company went IPO on 2017-10-20. Its business is focused on the launch of EXXUA and its prescription pharmaceutical products sold primarily through third-party wholesalers and pharmacies and which primarily consists of two product portfolios. Its Attention Deficit Hyperactivity Disorder (ADHD) portfolio consists of Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) , Cotempla XR-ODT, and METADATE CD, which are CNS stimulants indicated for the treatment of ADHD in patients. Its Pediatric portfolio consists of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine indicated to treat various allergic conditions including seasonal and perennial allergic rhinitis, vasomotor rhinitis, Poly-Vi-Flor, and Tri-Vi-Flor. EXXUA is indicated to treat depressive disorder (MDD) in adults.

Key Statistics of Aytu Biopharma Inc (AYTU)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.17$2.27

Today's Open

$2.27

Volume

75.97K

P/E Ratio (TTM)

52 Week Range

$1.46$3.07

Market Cap

27.58M

Avg. Volume

44.36K

Dividend Yield

Financial Metrics & Statements of Aytu Biopharma Inc (AYTU)

FAQ's for Aytu Biopharma Inc (AYTU)

According to Musaffa’s Shariah screening methodology, Aytu Biopharma Inc (AYTU) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.